Joshua R. Lamstein - 23 Nov 2021 Form 4 Insider Report for Scopus BioPharma Inc.

Role: Chairman, Director, 10%+ Owner
Signature: /s/ Joshua R. Lamstein
Issuer symbol: SCPS on OTC
Transactions as of: 23 Nov 2021
Net transactions value: $0
Form type: 4
Filing time: 26 Nov 2021, 16:01:05 UTC
Previous filing: 27 Aug 2021
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SCPS	W Warrants	Other		-3,000,000	-100%		0	23 Nov 2021	B Unit	3,000,000	$4.00	HCFP/Capital Partners 18B-2 LLC	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person is a member and co-manager of HCFP/Capital Partners 18B-2 LLC ("HCFP 18B-2"). On November 23, 2021, HCFP 18B-2, pursuant to a Warrant Contribution Agreement by and between the Issuer and HCFP 18B-2, agreed to contribute its 3,000,000 W Warrants back to the Company in exchange for the Company cancelling a $1.5 million contingent promissory note, including any and all interest, owed by HCFP 18B-2 to the Company.

Content

The Reporting Person is a member and co-manager of HCFP/Capital Partners 18B-2 LLC ("HCFP 18B-2"). On November 23, 2021, HCFP 18B-2, pursuant to a Warrant Contribution Agreement by and between the Issuer and HCFP 18B-2, agreed to contribute its 3,000,000 W Warrants back to the Company in exchange for the Company cancelling a $1.5 million contingent promissory note, including any and all interest, owed by HCFP 18B-2 to the Company.